Literature DB >> 12495219

Expression of heparan sulphate N-deacetylase/N-sulphotransferase by vascular smooth muscle cells.

John A Bingley1, Ian P Hayward, Adeeb A Girjes, Gordon R Campbell, Donald E Humphries, Jennifer L Stow, Julie H Campbell.   

Abstract

Heparan sulphate is an important mediator in determining vascular smooth muscle cell (SMC) phenotype. The sulphation pattern of the heparan sulphate chains is critical to their function. We have examined the initial step in the biosynthesis of the sulphated domains mediated by the enzyme heparan sulphate N-deacetylase/N-sulphotransferase (NDST). Rabbit aortic SMC in primary culture exhibited NDST enzyme activity and expressed NDST-1 in their Golgi apparatus, with maximal expression in SMC 2 days after dispersal in primary culture confirmed by Western blot analysis. Endothelial cells, macrophages and fibroblasts expressed NDST-1 but had generally less intense staining than SMC, although SMC expression decreased with culture. The uninjured rat aorta also showed widespread expression of NDST-1. After balloon de-endothelialisation, NDST-1 could not be detected in SMC of the neointima in the early stages of neointimal formation, but was re-expressed at later time points (after 12 weeks). In human coronary arteries, SMC of the media and the diffuse intimal thickening expressed NDST-1, while SMC in the atherosclerotic plaque were negative for NDST-1. We conclude that SMC may regulate their heparan sulphate sulphation at the level of expression of the enzyme heparan sulphate NDST in a manner related to their phenotypic state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12495219     DOI: 10.1023/a:1020938430120

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  1 in total

1.  In vivo antithrombotic synergy of oral heparin and arginine: endothelial thromboresistance without changes in coagulation parameters.

Authors:  Bruce Daniels; Robert J Linhardt; Fuming Zhang; Wenjun Mao; Sandra M Wice; Linda M Hiebert
Journal:  Thromb Haemost       Date:  2006-05       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.